Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jennifer Doudna
AddedMar 31, 2024
UpdatedJun 28, 2026
Jennifer Doudna

Jennifer Doudna

Board Member, Johnson & Johnson

Crunchbase

Jennifer Doudna's Career

Johnson & Johnson
Johnson & Johnson

New York City, NY, US

Board Member· Board
Caribou Biosciences
Caribou Biosciences

Berkeley, CA, US

Co-Founder
Editas Medicine
Editas Medicine

Cambridge, MA, US

Co-Founder
Intellia Therapeutics
Intellia Therapeutics

Cambridge, MA, US

Co-Founder
Innovative Genomics Institute
Innovative Genomics Institute

Berkeley, CA, US

Founder
Scribe Therapeutics
Scribe Therapeutics

Alameda, CA, US

Co-Founder
Inari Agriculture
Inari Agriculture

Cambridge, MA, US

Board Member· Board
Mammoth Biosciences
Mammoth Biosciences

San Francisco, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jennifer Doudna's Career

Johnson & Johnson
Johnson & Johnson
Public152.7k1886New Brunswick, NJ, US
Board Member· Board

Leadership at Johnson & Johnson

Mary BeckerleMary BeckerleBoard Member
Hubert JolyHubert JolyBoard Member
Nadja Y. WestNadja Y. WestBoard Member
Tom CavanaughTom CavanaughBoard Member
Ian DavisIan DavisBoard Member
William PerezWilliam PerezBoard Member

Similar to Johnson & Johnson

JanssenJanssenBeerse, Antwerp, BEPharmaceuticalsest. 1953JanssenBeerse, Antwerp, BE · est. 1953

Janssen, a Johnson & Johnson company in Italy, innovates to manage, interpret, and prevent diseases, ensuring affordable, effective healthcare worldwide.

Public255
Johnson & Johnson FoundationJohnson & Johnson FoundationNew Brunswick, NJ, USGlobal Health, Healthcareest. 1953Johnson & Johnson FoundationNew Brunswick, NJ, US · est. 1953

Johnson & Johnson Foundation: A charitable organization committed to advancing global health through science and ingenuity.

50
Johnson & Johnson Robotics and Digital SolutionsJohnson & Johnson Robotics and Digital SolutionsNew Brunswick, NJ, USHealthcare Solutionsest. 1973Johnson & Johnson Robotics and Digital SolutionsNew Brunswick, NJ, US · est. 1973

Johnson & Johnson Innovation: Advancing healthcare solutions through collaboration, funding, and global market access.

33
Becton DickinsonBecton DickinsonFranklin Lakes, NJ, USMedical Suppliesest. 1897Becton DickinsonFranklin Lakes, NJ, US · est. 1897

Global medical supplies manufacturer in Franklin Lakes, NJ, serving healthcare institutions and professionals worldwide.

Public · $579M75k
Caribou Biosciences
Caribou Biosciences
Public$317.7M1372011Berkeley, CA, US
Co-Founder

Leadership at Caribou Biosciences

Santhosh PalaniSanthosh PalaniBoard Member
Robert WeisskoffRobert WeisskoffBoard Member
Martin JinekMartin JinekCo-Founder
Scott BraunsteinScott BraunsteinBoard Member
Ran ZhengRan ZhengBoard Member
Andrew GuggenhimeAndrew GuggenhimeBoard Member
Editas Medicine
Editas Medicine
Public$931.6M2262013Cambridge, MA, US
Co-Founder

Leadership at Editas Medicine

J. Keith JoungJ. Keith JoungBoard Member
David R. LiuDavid R. LiuBoard Member
Akshay VaishnawAkshay VaishnawBoard Member
Gilmore O’NeillGilmore O’NeillBoard Member
Feng ZhangFeng ZhangBoard Member
Meeta ChatterjeeMeeta ChatterjeeBoard Member
Intellia Therapeutics
Intellia Therapeutics
Public$1.2B5982014Cambridge, MA, US
Co-Founder

Leadership at Intellia Therapeutics

Nessan BerminghamNessan BerminghamCo-Founder
Rodolphe BarrangouRodolphe BarrangouCo-Founder
Jean-François FormelaJean-François FormelaBoard Member
Luciano MarraffiniLuciano MarraffiniCo-Founder
Andy MayAndy MayCo-Founder
Rachel HaurwitzRachel HaurwitzCo-Founder
Innovative Genomics Institute
Innovative Genomics Institute
NonprofitNonprofit$11M1182014Berkeley, CA, US
Founder

Leadership at Innovative Genomics Institute

Steven M. AltschulerSteven M. AltschulerBoard Member
Renee WegrzynRenee WegrzynBoard Member
Scribe Therapeutics
Scribe Therapeutics
Late Stage Private$120M1212017Alameda, CA, US
Co-Founder

Leadership at Scribe Therapeutics

Benjamin L OakesBenjamin L OakesCo-Founder
David SavageDavid SavageCo-Founder
Carl L. GordonCarl L. GordonBoard Member
Brett T StaahlBrett T StaahlCo-Founder
Inari Agriculture
Inari Agriculture
Series F$609M4652016Cambridge, MA, US
Board Member· Board

Leadership at Inari Agriculture

Ignacio MartinezIgnacio MartinezCo-Founder & CEO
Sophie VandebroekSophie VandebroekBoard Member
George ChurchGeorge ChurchBoard Member
Michael MackMichael MackBoard Member
Ponsi TrivisvavetPonsi TrivisvavetBoard Member
David BerryDavid BerryCo-Founder

Similar to Inari Agriculture

IndigoIndigoBoston, MA, USAgricultural Productsest. 2013IndigoBoston, MA, US · est. 2013

Based in Boston, Indigo Agriculture, Inc. enhances agricultural production globally through microbial and digital technologies.

Late Stage Private · $1.4B1.7k
Sound AgricultureSound AgricultureEmeryville, CA, USCrop Solutionsest. 2012Sound AgricultureEmeryville, CA, US · est. 2012

Sound Agriculture: Innovating crop solutions for climate-resilient farming and enhanced yields, US-based.

Series D · $170.4M168
Pairwise PlantsPairwise PlantsDurham, NC, USCrop Developmentest. 2017Pairwise PlantsDurham, NC, US · est. 2017

Pairwise Plants, LLC: A global agricultural firm specializing in developing new crop varieties.

Series B · $115M75
VoloAgri GroupVoloAgri GroupSouth San Francisco, CA, USAgriculture, Seedest. 2012VoloAgri GroupSouth San Francisco, CA, US · est. 2012

VoloAgri Group Inc.: Nationwide provider of management and financing solutions for agricultural companies.

Series A · $127M200
Mammoth Biosciences
Mammoth Biosciences
Series D$264.5M1952017San Francisco, CA, US
Co-Founder

Recent news

VC firm NFX laid off 4 employees and plans to hire more investorsTechCrunch · 2024
Curing disease with CRISPR with Trevor Martin from Mammoth BiosciencesTechCrunch · 2023

Leadership at Mammoth Biosciences

Janice ChenJanice ChenCo-Founder
Maneesh JainManeesh JainBoard Member
Trevor MartinTrevor MartinCo-Founder
Lucas HarringtonLucas HarringtonCo-Founder
Ursheet ParikhUrsheet ParikhBoard Member

Jennifer Doudna's Co-Investors

Jamie CateJamie CateCo-invested · Huue Series AJamie CateJamie CateCo-invested · Huue Series AJerry YangJerry YangCo-invested · Synthego Series BU.C. BerkeleyU.C. BerkeleyCo-invested · Caribou Biosciences Series AJesse RobbinsJesse RobbinsCo-invested · Caribou Biosciences Series CCyriac RoedingCyriac RoedingCo-invested · Synthego Series CZachary HargreavesZachary HargreavesCo-invested · Synthego Series CShu DuanShu DuanCo-invested · Caribou Biosciences Series B

Jennifer Doudna's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Jennifer Doudna

Frances ArnoldFrances ArnoldBoard Member · AlphabetDavid GoeddelDavid GoeddelBoard Member · NGM BiopharmaceuticalsJay ShendureJay ShendureBoard Member · Adaptive BiotechnologiesBob LangerBob LangerCo-Founder · SQZ Biotechnologies